argenx announced it will acquire Unnatural Products, Inc. (UNP) for up to $1.15 billion, including upfront and milestone payments. This acquisition adds UNP's macrocyclic peptide discovery platform to argenx's antibody engineering capabilities, broadening its ability to develop novel immunology treatments, including potential oral and long-acting medicines. UNP will continue operating from Santa Cruz, California, maintaining its team and culture, while argenx will leverage its clinical and commercialization expertise to advance new therapies. The deal follows over two years of collaboration and is expected to close by the end of 2026, pending regulatory approvals.
argenx's acquisition of Unnatural Products, Inc. provides context for health-sector market activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 09, 2026 13:11 WIB: out of 150 priced US health-sector stocks, 61 rose and 85 fell. Notable movers include CGC (Canopy Growth Corp) at USD 0.66 with a 1-day change of -12.85% and a typical hold time of 40 days, NUVB (Nuvation Bio Inc. Class A Common Stock) at USD 4.16 down 12.05% with a 12-day hold, and TXG (10X Genomics Inc) at USD 60.32 down 10.66% with a 92-day hold time.
Dapirolizumab pegol (DZP), an investigational biologic for systemic lupus erythematosus (SLE), demonstrated greater treatment response rates compared to placebo when combined with standard care in the Phase 3 PHOENYCS GO trial. Using a novel Treatmen...
Valneva announced positive Phase 2 trial results for its tetravalent Shigella vaccine candidate S4V2, showing a favorable safety profile and encouraging immune responses in infants and adults. The infant trial in Kenya demonstrated significant antibo...
argenx will acquire Unnatural Products (UNP) for $550 million upfront plus up to $600 million in milestones, totaling about $1.15 billion. UNP specializes in orally-delivered macrocyclic peptides targeting previously undruggable diseases, enhancing a...
ClearPoint Neuro reported solid third-quarter results, driven by increased revenue from its drug delivery services and steady sales in neurosurgery navigation equipment. The company sees encouraging signs for future growth in disposables linked to ca...
Within a three-hour period ending Nov. 7, three large Bitcoin transfers totaling $386.3 million were recorded. The biggest transaction moved 1,985 BTC ($150.8M) between unknown wallets, followed by another wallet-to-wallet transfer of 1,694 BTC ($128...
